The protein abundance of SAMD5 in clinical breast cancer and paired non-tumor tissues was assessed using immunohistochemistry (IHC); as shown in Figure 5C, SAMD5 levels were remarkably lower in breast carcinoma samples. The gene discussed is SAMD5; the disease is neoplasm.